Literature DB >> 2839419

Monocyte and polymorphonuclear leukocyte toxic oxygen metabolite production in multiple sclerosis.

M Fisher1, P H Levine, B H Weiner, C H Vaudreuil, A Natale, M H Johnson, J J Hoogasian.   

Abstract

Lipid-laden macrophages, which are predominantly derived from blood monocytes, are present at sites of active multiple sclerosis demyelination and are assumed to be involved in the demyelinating process. These inflammatory cells produce a variety of toxic oxygen metabolites which can mediate host tissue destruction. We measured production of two oxygen metabolites by monocytes and polymorphonuclear leukocytes in MS patients and controls. Stimulated monocytes produced significantly more hydrogen peroxide, superoxide, and chemiluminescence in the MS group than controls. The polymorphonuclear leukocyte, an inflammatory cell that appears to contribute little to MS demyelination, did not demonstrate increased production of toxic oxygen metabolites in the MS patients as compared to controls. These results suggest that blood monocytes in MS patients are primed to produce increased amounts of cytotoxic oxygen metabolites when exposed to inflammatory stimuli.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839419     DOI: 10.1007/BF00916395

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  28 in total

1.  A sensitive method for the estimation of hydrogen peroxide in biological materials.

Authors:  W A ANDREAE
Journal:  Nature       Date:  1955-05-14       Impact factor: 49.962

2.  Source of hydrogen peroxide and of chemiluminescence observed in activated human platelet preparations.

Authors:  N I Krinsky; K L Scoon; J C Hardin; P H Levine
Journal:  Blood       Date:  1977-10       Impact factor: 22.113

3.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

4.  Pathology of the Guillain-Barré syndrome.

Authors:  J W Prineas
Journal:  Ann Neurol       Date:  1981       Impact factor: 10.422

Review 5.  Oxygen-derived free radicals in postischemic tissue injury.

Authors:  J M McCord
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

6.  Cytotoxicity of human macrophages for tumor cells. Enhancement by human lymphocyte mediators.

Authors:  D J Cameron; W H Churchill
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

7.  Multiple sclerosis. Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages.

Authors:  U Traugott; E L Reinherz; C S Raine
Journal:  J Neuroimmunol       Date:  1983-06       Impact factor: 3.478

8.  Multiple sclerosis patients show an increased spontaneous activity of their peripheral blood monocytes as measured by chemiluminescence.

Authors:  K P Hammann; W Nix; M P Dierich; H C Hopf
Journal:  Acta Neurol Scand       Date:  1983-09       Impact factor: 3.209

9.  Lymphokines enhance the capacity of human monocytes to secret reactive oxygen intermediates.

Authors:  A Nakagawara; N M DeSantis; N Nogueira; C F Nathan
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

10.  Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium.

Authors:  M Kurosaka; M Ziff
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

View more
  6 in total

1.  Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T.

Authors:  I-Y Choi; S-P Lee; D R Denney; S G Lynch
Journal:  Mult Scler       Date:  2010-10-04       Impact factor: 6.312

Review 2.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

3.  Expression of urokinase plasminogen activator receptor on monocytes from patients with relapsing-remitting multiple sclerosis: effect of glatiramer acetate (copolymer 1).

Authors:  R Balabanov; D Lisak; T Beaumont; R P Lisak; P Dore-Duffy
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

4.  Baseline gene expression signatures in monocytes from multiple sclerosis patients treated with interferon-beta.

Authors:  Marta F Bustamante; Ramil N Nurtdinov; Jordi Río; Xavier Montalban; Manuel Comabella
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

Review 5.  Albumin and multiple sclerosis.

Authors:  Steven M LeVine
Journal:  BMC Neurol       Date:  2016-04-12       Impact factor: 2.474

Review 6.  Demyelination: the role of reactive oxygen and nitrogen species.

Authors:  K J Smith; R Kapoor; P A Felts
Journal:  Brain Pathol       Date:  1999-01       Impact factor: 6.508

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.